Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.

Bo Ahrén, Chantal Mathieu, Giovanni Bader, Anja Schweizer, James E Foley

Research output: Contribution to journalArticlepeer-review

732 Downloads (Pure)

Abstract

Randomised control trials (RCTs) do not always reflect real-life outcomes for glucose-lowering drugs. In this work we compared RCT and real-life data on the efficacy of the dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin or sulfonylureas when added to metformin.
Original languageEnglish
Pages (from-to)1304-1307
JournalDiabetologia
Volume57
Issue number7
DOIs
Publication statusPublished - 2014

Subject classification (UKÄ)

  • Endocrinology and Diabetes

Fingerprint

Dive into the research topics of 'Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.'. Together they form a unique fingerprint.

Cite this